Perrigo | PRGO - Debt


Perrigo reported $3.63B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
AbbVie USD 72.86B 5.36B Mar/2026
Abbott USD 34.05B 20.19B Mar/2026
Bayer EUR 36.45B 2.93B Dec/2025
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
Coherus Biosciences USD 294.92M 1.25M Mar/2025
Corcept Therapeutics USD 9.64M 3.53M Mar/2026
Dr.Reddys Laboratories INR 71.95B 5.39B Jun/2026
Eli Lilly USD 43.37B 867M Mar/2026
J&J USD 54.99B 7.05B Mar/2026
Merck USD 49.12B 222M Mar/2026
Nestle CHF 57.85B 3.54B Dec/2025
Pacira USD 363.12M 4.53M Jun/2026
Perrigo USD 3.63B 7.7M Mar/2026
Pfizer USD 63.19B 536M Jun/2026
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 1.05B 33.86M Mar/2026
Reckitt Benckiser GBP 8.66B 238M Dec/2024
Sanofi EUR 23.58B 3.56B Jun/2026
Supernus Pharmaceuticals USD 40.17M 733K Jun/2026
Teva Pharmaceutical Industries USD 16.91B 187M Mar/2026
Xeris Pharmaceuticals USD 258.55M 899K Mar/2026
Zoetis USD 9.24B 0 Mar/2026